Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Massimiliano Mulè

Assistant Professor

Università degli Studi di Enna Kore

Italy

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Italy

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (5)

Holger Thiele

GERMANY

View details

Stefano Ghio

Università di Pavia/Fondazione IRCCS Policlinico San Matteo

ITALY

View details

paolo manca

Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione

ITALY

View details

Roberto Badagliacca

Sapienza University of Rome

ITALY

View details

Caterina Gandolfo

Clinical Assistant Professor of Medicine Director of Interventional Cardiology Unit Director of Structural Heart Disease Transcatheter Interventions

Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Massimiliano Mulè

Research Interests

Make your next move.

Explore related searches

Articles (20)

Pulmonary arterial hypertension: right ventricular phenotyping to improve risk assessment at follow-up

Prognostic role of invasively determined pulmonary hypertension in ambulatory patients with advanced heart failure: a prospective cohort study

2025 expert consensus on the use of parenteral prostanoids in incident and prevalent PAH patients: The Italian perspective

ASPYRE-1 study: An Italian multicenter prospective study on pulmonary hypertension modality of death and validation of REVEAL risk score

Longitudinal Trajectories of Secondary Mitral Regurgitation in Nonischemic Dilated Cardiomyopathy

The quantitative haemodynamic effect of levosimendan, dobutamine, and milrinone in heart failure patients: a meta-analysis

Value of right heart haemodynamics for risk stratification of patients with pulmonary arterial hypertension at follow-up

Right ventricular global work efficiency: A reliable non‐invasive estimate of right ventricular contractility

Gaps and Knowledge in the Contemporary Management of Acute Right Ventricular Failure

TAPSE/sPAP Ratio to Improve Risk Assessment in Pulmonary Arterial Hypertension

ISMETT experience with long-term left ventricular assist devices,L’esperienza ISMETT con i supporti meccanici al circolo di lunga durata

Functional Mitral Valve Regurgitation, Pathophysiology, Leaflet ReModeling, and the Role of Imaging

MAD or MADness?

The role of left atrio-ventricular coupling index and left atrial ejection fraction in predicting onset of atrial fibrillation and adverse cardiac events in hypertrophic cardiomyopathy

Right ventricular phenotyping in incident patients with idiopathic pulmonary arterial hypertension

Relevance of Echocardiography-derived Phenotyping in Patients with Pulmonary Arterial Hypertension Treated with Initial Oral Combination Therapy: An Italian Pulmonary Hypertension Network (iPHNET) Study

Contemporary clinical role of echocardiography in patients with advanced heart failure

Gaps in evidence in the management of patients with intermediate-risk pulmonary arterial hypertension: Considerations following the ESC/ERS 2022 guidelines

Gaps in evidence in the treatment of prevalent patients with pulmonary arterial hypertension at intermediate risk: An expert consensus

SGLT2 inhibitor therapy in patients with advanced heart failure and reduced ejection fraction

Collaborators (5)

Holger Thiele

Stefano Ghio

paolo manca

Roberto Badagliacca

Caterina Gandolfo

Make your next move.